New York, Oct 4 (IANS) Scientists on Friday revealed that a cholesterol regulator can become a surprising player in mental health research, helping treat depression and anxiety.
Called LXRβ, the nuclear receptor is known for its role in cholesterol metabolism and inflammation. It is now emerging as a crucial player in neuroscience and psychiatry.
In a review, published in the journal Brain Medicine, researchers Dr Xiaoyu Song and Professor Jan-Ake Gustafsson from the University of Houston and Karolinska Institutet (Sweden) shed light on the therapeutic potential of liver anxiety.
This comprehensive analysis marks a significant step forward in understanding the molecular underpinnings of mental health disorders and potentially revolutionizing their treatment.
“Our analysis reveals that the receptor plays a pivotal role in preventing central nervous system disease in experimental rodent models,” said Dr Song. If these observations translate to humans, it could emerge as a novel therapeutic target for treating neuropsychiatric disorders, particularly depression and anxiety.
According to the findings, the receptor’s deficiency in female mice leads to anxiety-like behavior and impaired behavioral responses.
The activation of the regulator in the amygdala exerts anxiolytic effects by rebalancing excitatory and inhibitory neurotransmission, it added.
Its signaling also regulates neurogenesis and enhances cognitive function, which may have implications for treating depression.
The review also explores its role in autism spectrum disorder (ASD), suggesting potential connections between cholesterol metabolism, brain development, and ASD symptoms.
Professor Gustafsson said the connection between the receptor, traditionally associated with metabolic functions, and complex psychiatric disorders like depression and anxiety, underscores the interconnectedness of biological systems.
It challenges us to think more holistically about mental health and its underlying molecular mechanisms, the professor added.
While the findings are promising, the authors caution that additional basic research and clinical trials are necessary to determine whether novel drugs targeting the receptor can be effectively utilized in treating neurological and neuropsychiatric diseases.
-IANS
no/
Go to Source
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event we will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website. .
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source,
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
